Can cabotegravir treat HIV (AIDS)?

Cabotegravir (Cabotegravir) is an antiretroviral drug used to treat HIV (human immunodeficiency virus) infection. It belongs to the category of integrase inhibitors. By inhibiting the integrase activity of HIV, it prevents the virus from transcribing its RNA into the DNA of the host cell and integrating it into the genome of the host cell. In this way, cabotegravir can effectively inhibit the replication and reproduction of the HIV virus, thereby reducing the amount of the virus in the host body.

Cabotegravir is often given as part of combination antiretroviral therapy (cART). Combination therapy uses two or more antiretroviral drugs of different classes at the same time to slow down the replication of HIV viruses, reduce viral load, improve immune function, and delay the progression of HIV disease. Combination therapy can effectively control viral replication and reduce the amount of virus in the body, thereby maintaining the patient's immune function, slowing down the progression of HIV disease, and improving the patient's quality of life.

Please note that cabotegravir is a prescription medication and must be used under the supervision of a doctor. Patients should use drugs strictly in accordance with the doctor's recommendations and treatment plan, and conduct regular follow-up and evaluation. Only by using drugs correctly under the guidance of a doctor can you achieve the best therapeutic effect and reduce the risk of adverse reactions. If you or someone you know is infected withHIV, it is recommended to consult a professional doctor as soon as possible and receive appropriate treatment.

Cabotegravir is not currently on the market in China, so patients cannot purchase it domestically and need to purchase cabotegravir through overseas channels. Foreign cabotegravir only has original drugs, mainly European original drugs, and the price is very high, about 16,000 yuan.